Transcriptional Dynamics of Neuronal Differentiation
Transcriptional Dynamics of Neuronal Differentiation
批准号:
7232204
负责人:
Anne Eliane CHIARAMELLO
金额:
$2.5万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2007-06-30
关键词:
DNA footprintingPC12 cellsapoptosisbiological signal transductioncell differentiationgel mobility shift assaygene expressionimmunocytochemistrymicroarray technologyneurogenesisneuronsneurotrophic factorspolymerase chain reactionprotein structureprotein structure functiontissue /cell culturetranscription factorwestern blottings
中文摘要
描述(摘自申请人的摘要):
这个项目的主要目标是剖析
控制神经元分化、维持的转录网络
和生存。这个应用程序特别关注转录
神经元特异性基本螺旋-环-螺旋(BHLH)控制的动力学
转录因子Nex1/Math-2,它是神经D亚家族的成员。
我们的研究表明,Nex1是神经元的关键调节因子
区分程序作为它的表达方式,对于执行
NGF诱导分化途径。其在PC12细胞中的过表达诱导
神经细胞突起生长及神经元标记物GAP-43的表达
不依赖于NGF的方式。最重要的是,我们的研究揭示了第一个证据
Nex1可以阻止NGF剥夺的PC12细胞的凋亡。因此,bHLHNex1
可能是连接终端分化和维护的关键因素
分化的神经元存活。来检验我们的假设并阐明
Nex1在神经元分化和存活过程中的转录功能
我们计划进行以下三个目标中概述的实验。我们的
战略将使用大鼠嗜铬细胞瘤细胞系PC 12,因为它是一种
建立完善的研究神经元分化、维持和
生死存亡。目的我将重点介绍Nex1调控的转录途径
导致终末神经元分化。最初,我们将生成一个
双稳定的Nex1可诱导的PC 12细胞系将允许操纵
Nex I表达的时间和水平。我们将确定其程度
通过评估神经元标志物的水平来研究神经元分化
免疫印迹和免疫细胞化学相结合。最后,我们将表演一个
Nex1诱导分化不同阶段的动态基因图谱
差异显示和cDNA微阵列。AIM II将针对
Nex1促进神经元存活的分子机制。我们将衡量
逆转录-聚合酶链式反应检测抗凋亡和促凋亡基因的表达
使用我们稳定的细胞系,神经元标志物的时间表达。
最后,Aim III将探索控制Nex1的转录机制
在NGF诱导的分化途径中的表达,使用联合
DNase I足迹、EMSA和CAT分析。事实是Nex1
显示出神经保护特性,使其成为有望增强的目标
神经元存活和设计新的治疗方法
神经退行性疾病、与年龄相关的神经元障碍和中枢神经系统损伤。
英文摘要
DESCRIPTION (From the Applicant's Abstract):
The main objective of this project is to dissect the underlying mechanisms of
the transcriptional network controlling neuronal differentiation, maintenance
and survival. This application specifically focuses on the transcriptional
dynamics controlled by the neuronal-specific basic Helix-Loop-Helix (bHLH)
transcription factor Nexl/Math-2, which is a member of the NeuroD subfamily.
Our studies suggest that Nex 1 is a key regulator of the neuronal
differentiation program as its expression is important to the execution of the
NGF-induced differentiation pathway. Its overexpression in PC12 cells induces
neurite outgrowth and expression of the neuronal marker GAP-43 in an
NGF-independent manner. Most importantly, our studies reveal the first evidence
that Nex 1 prevents apoptosis of NGF-deprived PC12 cells. Thus, the bHLH Nex 1
may be a key factor linking terminal differentiation to maintenance and
survival of differentiated neurons. To test our hypotheses and to elucidate the
transcriptional functions of Nex1 during neuronal differentiation and survival,
we plan to execute the experiments outlined in the three following aims. Our
strategy will employ the rat pheochromocytoma cell line, PC 12, as it is a
well-established system to study neuronal differentiation, maintenance, and
survival. Aim I will focus on the Nex 1-modulated transcriptional pathways
leading to terminal neuronal differentiation. Initially, we will generate a
double stable Nex 1 inducible PC 12 cell line that will permit the manipulation
of both the timing and levels of Nex I expression. We will determine the extent
of neuronal differentiation by assessing the level of neuronal markers using a
combination of western blot and immunocytochemistry. Finally, we will perform a
dynamic gene profiling at different stages of Nex1-induced differentiation by
differential display and cDNA expression microarray. Aim II will address the
molecular mechanisms by which Nex1 promotes neuronal survival. We will measure
the expression of anti-apoptotic and pro-apoptotic genes by RT-PCR, as well as
the temporal expression of neuronal markers, using our stable cell lines.
Finally, aim III will explore the transcriptional mechanisms controlling Nex1
expression in the NGF-induced differentiation pathway, using a combination of
DNase I footprinting, EMSA, and CAT assay analyses. The fact that Nex 1
exhibits neuroprotective properties makes it a promising target to enhance
neuronal survival and design novel therapeutical approaches to treat
neurodegenerative diseases, age-related neuronal disorders, and CNS injuries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
-
批准号:10702207
-
项目类别:
-
资助金额:$95.71万
-
财政年份:2021
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
-
批准号:10439890
-
项目类别:
-
资助金额:$55.7万
-
财政年份:2021
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies
-
批准号:10301261
-
项目类别:
-
资助金额:$57.48万
-
财政年份:2021
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
A Pharmaco-Epigenomic Intervention for the Mitochondrial Disorder MELAS
-
批准号:8891656
-
项目类别:
-
资助金额:$40.84万
-
财政年份:2015
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Survival
-
批准号:7258219
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Differentiation
-
批准号:6318508
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Differentiation
-
批准号:6618037
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Survival
-
批准号:7662331
-
项目类别:
-
资助金额:$39.46万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Survival
-
批准号:7659004
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Differentiation
-
批准号:6540422
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Survival
-
批准号:8055717
-
项目类别:
-
资助金额:$7.64万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Survival
-
批准号:7475700
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Differentiation
-
批准号:6761810
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
Transcriptional Dynamics of Neuronal Survival
-
批准号:7913101
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2001
-
负责人:Anne Eliane CHIARAMELLO
-
依托单位:
海外基金